Linked Data API

Show Search Form

Search Results

1126321
star this property registered interest false more like this
star this property date less than 2019-05-13more like thismore than 2019-05-13
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Gender Recognition: Children more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government whether they intend to publish the results of the research project started in 2011 by the NHS Gender Identity Development Service Early pubertal suppression in a carefully selected group of adolescents with gender identity disorder; and if not, whether they will arrange for the data gathered by that study to be made available to other researchers. more like this
star this property tabling member printed
Lord Lucas more like this
star this property uin HL15681 more like this
star this property answer
answer
unstar this property is ministerial correction true more like this
unstar this property date of answer less than 2019-05-22more like thismore than 2019-05-22
star this property answer text <p>The research is an ethically approved study being carried out by the Tavistock and Portman NHS Foundation Trust since 2011, which is the largest provider of services for the alleviation of gender dysphoria in the United Kingdom.</p><p>The study will evaluate early pubertal suppression in a carefully selected group of adolescents with a clinical diagnosis of gender dysphoria. There are 44 young people taking part in the study.</p><p>The Tavistock and Portman NHS Foundation Trust has plans to publish the data <ins class="ministerial">on the blocker and cross-sex hormones, for those who were appropriate for this, as</ins><del class="ministerial">once</del> all of the young people in the study have reached <ins class="ministerial">this</ins><del class="ministerial">the</del> stage<ins class="ministerial">.</ins> <del class="ministerial">when a clinical decision is made about moving from pubertal suppressants to cross-sex hormones, which the Trust expects to occur in the next 12 months.</del></p>
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property question first answered
less than 2019-05-22T14:51:30.447Zmore like thismore than 2019-05-22T14:51:30.447Z
star this property question first ministerially corrected
less than 2019-07-31T15:30:59.74Zmore like thismore than 2019-07-31T15:30:59.74Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property previous answer version
119577
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
1879
unstar this property label Biography information for Lord Lucas more like this
1128442
star this property registered interest false more like this
star this property date less than 2019-05-23more like thismore than 2019-05-23
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cannabis: Medical Treatments more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if he will publish the evidence (a) his Department and (b) the Department for International Trade holds on growing a market for prescribed medicinal cannabis. more like this
star this property tabling member constituency Hemel Hempstead more like this
star this property tabling member printed
Sir Mike Penning more like this
star this property uin 257706 more like this
star this property answer
answer
unstar this property is ministerial correction true more like this
unstar this property date of answer less than 2019-06-10more like thismore than 2019-06-10
star this property answer text <p><ins class="ministerial"> <p><ins class="ministerial">The Department for International Trade and the Department of Health and Social Care are not specifically collecting data on the growth of the market for cannabis based products for medicinal use in the United Kingdom.</ins></p><p><ins class="ministerial">However, data from the Medicines and Healthcare products Regulatory Agency (MHRA) shows growing numbers of import notifications for medicinal cannabis and the Home Office has received increased numbers of licence applications.</ins></p><p><ins class="ministerial">In addition, UK companies exporting these products and foreign companies looking to invest in the UK have full access to government support, where they have the necessary authorisations from the MHRA and Home Office and a relevant Export Licence.</ins></p></ins></p><p><del class="ministerial">An initial impact assessment was published alongside The Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018. This can be viewed at the following link:</del></p><p><del class="ministerial"><a href="http://www.legislation.gov.uk/uksi/2018/1055/impacts" target="_blank">http://www.legislation.gov.uk/uksi/2018/1055/impacts</a></del></p><p><del class="ministerial">This set out the approach that the Government proposed to take in assessing the costs and benefits of the change in the law at a population level, with regard to the rescheduling of cannabis-based products for medicinal use (CBPM). This framework included potential savings in treatment costs, giving the example of patients with severe epilepsy for whom medicinal use of cannabis could reduce the frequency of seizures and reduce the number of related hospital admissions. This was an initial framework for assessing this policy and as we develop our knowledge in this area, both on the costs and the potential benefits, we can revisit and refine these assessments.</del></p><p><del class="ministerial">In the meantime, the National Institute for Health and Care Excellence (NICE) is developing clinical guidelines on the appropriate use of CBPM based on the best available evidence, and the National Institute for Health Research is funding further clinical research on this. More information is available at the following link:</del></p><p><del class="ministerial"><a href="https://www.nihr.ac.uk/funding-and-support/documents/themed-calls/cannabis-based%20products/cannabis-based-products-brief.pdf" target="_blank">https://www.nihr.ac.uk/funding-and-support/documents/themed-calls/cannabis-based%20products/cannabis-based-products-brief.pdf</a></del></p>
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-06-10T13:18:03.37Zmore like thismore than 2019-06-10T13:18:03.37Z
star this property question first ministerially corrected
less than 2019-06-11T11:31:21.83Zmore like thismore than 2019-06-11T11:31:21.83Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property previous answer version
121340
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
1528
unstar this property label Biography information for Sir Mike Penning more like this
1129191
star this property registered interest false more like this
star this property date less than 2019-06-03more like thismore than 2019-06-03
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Prescription Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, how many prescriptions of (a) individual benzodiazepine drugs and (b) individual antidepressants were dispensed in the community in 2018. more like this
star this property tabling member constituency Bristol North West more like this
star this property tabling member printed
Darren Jones more like this
star this property uin 259400 more like this
star this property answer
answer
unstar this property is ministerial correction true more like this
unstar this property date of answer less than 2019-06-11more like thismore than 2019-06-11
star this property answer text <p>Information on the number of prescription items from the Prescription Cost Analysis system for benzodiazepines and antidepressants written in the United Kingdom and dispensed in the community in England, for the year 2018 can be found in the attached tables.</p><p>The data available is at prescription item level by presentation. Prescriptions are prescribed either by a paper prescription form or via an Electronic Prescription Service message. Each single item written on the form is counted as a prescription item. No information is available for those prescriptions written but not dispensed.</p> more like this
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-06-11T16:51:00.313Zmore like thismore than 2019-06-11T16:51:00.313Z
star this property question first ministerially corrected
less than 2019-06-12T14:34:05.54Zmore like thismore than 2019-06-12T14:34:05.54Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property attachment
1
star this property file name PQ259400 table formatted.docx more like this
star this property title Prescription data benzodiazipines & antidepressant more like this
star this property previous answer version
122124
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
4621
unstar this property label Biography information for Darren Jones more like this
1132035
star this property registered interest false more like this
star this property date less than 2019-06-13more like thismore than 2019-06-13
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading General Practitioners more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what the requirements for primary care networks to engage with the local community will be. more like this
star this property tabling member constituency Newton Abbot more like this
star this property tabling member printed
Anne Marie Morris more like this
star this property uin 264406 more like this
star this property answer
answer
unstar this property is ministerial correction true more like this
unstar this property date of answer less than 2019-06-18more like thismore than 2019-06-18
star this property answer text <p><ins class="ministerial"> <p><ins class="ministerial">Primary Care Networks (PCNs) are a new way for primary and community service organisations to work together. For PCNs to be successful they will need to work in partnership with local people and the communities they serve. Legal duties which currently apply to NHS service providers - including general practitioner practices - and commissioners around engagement and consultation will continue to be valid for PCNs.</ins></p></ins></p><p><del class="ministerial">NHS England and NHS Improvement, together with the National Institute for Health and Care Excellence, is developing a ’commercial framework’ setting out the parameters for the commercial approach for medicines in the health service in England.</del></p><p><del class="ministerial">The commercial framework will support a single, transparent, robust and integrated pricing and market access process, and is being tested with and informed through consultation with stakeholders including the Association of the British Pharmaceutical Industry.</del></p><p><del class="ministerial">In preparation for public consultation in the coming months, NHS England is actively engaging with industry trade bodies and health system partners, in the first instance, to outline progress on the development of the commercial framework. The consultation on the draft framework is anticipated to be launched in Quarter 3 2019 with consultation events to be held in Manchester and London, and implementation of the commercial framework is expected to follow.</del></p>
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-06-18T16:34:05.507Zmore like thismore than 2019-06-18T16:34:05.507Z
star this property question first ministerially corrected
less than 2019-06-19T08:36:30.617Zmore like thismore than 2019-06-19T08:36:30.617Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property previous answer version
123829
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
4249
unstar this property label Biography information for Anne Marie Morris more like this
1125504
star this property registered interest false more like this
star this property date less than 2019-05-08more like thismore than 2019-05-08
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Pneumococcal Diseases: Vaccination more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what assessment they have made of the recommendations by the Joint Committee on Vaccination and Immunisation to reduce the infant pneumococcal vaccination schedule from three doses to two. more like this
star this property tabling member printed
Baroness Masham of Ilton more like this
star this property uin HL15599 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2019-05-22more like thismore than 2019-05-22
star this property answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) provides independent expert advice on the United Kingdom’s immunisation programme. As an independent committee, it is well placed to ensure the latest and most appropriate evidence has been considered on potential changes to scheduling within the vaccine programme. It bases its advice on review of a wide range of scientific and other evidence, including from the published literature, commissioned studies such as independent analyses of vaccine effectiveness and cost effectiveness.</p><p>The JCVI advised that a two-dose schedule for the infant pneumococcal conjugate vaccine (PCV) Prevenar13 is appropriate for the UK. Its advice takes into account the public health aspects of any potential change to the vaccination schedule, such as the potential impact on cases of infectious disease. The JCVI consulted relevant stakeholders on its proposed advice, between January and April 2018, to ensure that its advice reflects all the evidence.</p><p>The JCVI’s advice on the infant pneumococcal programme was given full consideration, including the potential public health implications, before a decision was made to implement it. The UK frequently adopts innovative immunisation schedules and we regularly change the vaccine schedule following the advice of our independent expert committee, as we are doing in this case.</p><p>The decision is based on the excellent effectiveness of the vaccine and years of high uptake, which has helped to provide protection to the rest of the population and has successfully controlled many types of pneumococcal disease in this country. The evidence shows that two doses will sustain the excellent results we have already seen. We are confident that the world-class disease surveillance system we have in this country means our expert committee can closely monitor the impact of this change. This is set out in the JCVI’s minutes which are attached.</p>
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property grouped question UIN HL15600 more like this
star this property question first answered
less than 2019-05-22T14:50:14.54Zmore like thismore than 2019-05-22T14:50:14.54Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property attachment
1
star this property file name JCVI Minute 2015 10 Attached to HL16000 and 15999.pdf more like this
star this property title JCVI Minute 2015 more like this
star this property tabling member
1850
unstar this property label Biography information for Baroness Masham of Ilton more like this
1125505
star this property registered interest false more like this
star this property date less than 2019-05-08more like thismore than 2019-05-08
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Pneumococcal Diseases: Vaccination more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what analyses they have conducted of the risks and benefits of reducing the infant pneumococcal vaccination schedule from 2+1 to 1+1; and whether they will publish the results any such analyses. more like this
star this property tabling member printed
Baroness Masham of Ilton more like this
star this property uin HL15600 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2019-05-22more like thismore than 2019-05-22
star this property answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) provides independent expert advice on the United Kingdom’s immunisation programme. As an independent committee, it is well placed to ensure the latest and most appropriate evidence has been considered on potential changes to scheduling within the vaccine programme. It bases its advice on review of a wide range of scientific and other evidence, including from the published literature, commissioned studies such as independent analyses of vaccine effectiveness and cost effectiveness.</p><p>The JCVI advised that a two-dose schedule for the infant pneumococcal conjugate vaccine (PCV) Prevenar13 is appropriate for the UK. Its advice takes into account the public health aspects of any potential change to the vaccination schedule, such as the potential impact on cases of infectious disease. The JCVI consulted relevant stakeholders on its proposed advice, between January and April 2018, to ensure that its advice reflects all the evidence.</p><p>The JCVI’s advice on the infant pneumococcal programme was given full consideration, including the potential public health implications, before a decision was made to implement it. The UK frequently adopts innovative immunisation schedules and we regularly change the vaccine schedule following the advice of our independent expert committee, as we are doing in this case.</p><p>The decision is based on the excellent effectiveness of the vaccine and years of high uptake, which has helped to provide protection to the rest of the population and has successfully controlled many types of pneumococcal disease in this country. The evidence shows that two doses will sustain the excellent results we have already seen. We are confident that the world-class disease surveillance system we have in this country means our expert committee can closely monitor the impact of this change. This is set out in the JCVI’s minutes which are attached.</p>
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property grouped question UIN HL15599 more like this
star this property question first answered
less than 2019-05-22T14:50:14.483Zmore like thismore than 2019-05-22T14:50:14.483Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property attachment
1
star this property file name JCVI Minute 2015 10 Attached to HL16000 and 15999.pdf more like this
star this property title JCVI Minute 2015 more like this
star this property tabling member
1850
unstar this property label Biography information for Baroness Masham of Ilton more like this
1125506
star this property registered interest false more like this
star this property date less than 2019-05-08more like thismore than 2019-05-08
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading HIV Infection: Vaccination more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what steps they are taking to improve vaccination coverage for people living with HIV. more like this
star this property tabling member printed
Baroness Masham of Ilton more like this
star this property uin HL15601 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2019-05-22more like thismore than 2019-05-22
star this property answer text <p>Public Health England, in partnership with NHS England and the Department, is taking steps to improve vaccination coverage in England, including for people living with HIV.</p><p>These steps include initiatives to improve access to the immunisation programme; communication with the public; data to identify underserved individuals and populations; and training for healthcare professionals, changes to vaccination eligibility criteria; launching disease elimination strategies; running targeted social media campaigns; providing information leaflets in multiple languages and running e-learning programme for healthcare practitioners.</p><p>Certain vaccines are delivered through sexual health services that particularly benefit people living with HIV. This includes vaccines for hepatitis A, hepatitis B and human papillomavirus. People living with HIV are in the influenza risk groups and are invited for the flu vaccine on an annual basis.</p> more like this
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property question first answered
less than 2019-05-22T14:50:46.107Zmore like thismore than 2019-05-22T14:50:46.107Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
1850
unstar this property label Biography information for Baroness Masham of Ilton more like this
1125517
star this property registered interest false more like this
star this property date less than 2019-05-08more like thismore than 2019-05-08
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading NHS: Migrant Workers more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what plans they have, if any, to increase the number of NHS staff recruited from EU member states after Brexit. more like this
star this property tabling member printed
Lord Taylor of Warwick more like this
star this property uin HL15612 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2019-05-22more like thismore than 2019-05-22
star this property answer text <p>The Government recognises the need to be able to recruit effectively from abroad and the Immigration White Paper, <em>The UK’s future skills-based immigration system</em>, published in December 2018, sets out the foundation for a single immigration system, where it is workers’ skills that matter, not where they come from. This system will streamline the high-skilled visa route, by removing the Resident Labour Market Test and the Tier 2 Visa Cap. The Home Office is undertaking a programme of engagement to discuss the proposed measures with colleagues across Government and industry, to develop a future immigration system that works for the whole of the United Kingdom.</p><p>The Government wants to support the National Health Service in expanding international recruitment more widely, as this clearly has a role to play to meeting staffing shortages, especially in the short term. Recruitment of doctors and nurses is the responsibility of individual NHS organisations, a number of which do actively recruit from overseas, including from countries in the European Union. However, we also recognise the need to boost our domestic workforce as well. The NHS Long Term Plan sets out a vital strategic framework to ensure that, over the next 10 years, the NHS will have the staff it needs so that nurses and doctors are working in a supportive culture that allows them to provide the expert compassionate care they are committed to providing. Details of this will be explored more fully in the forthcoming Interim NHS People Plan.</p><p>The Government has taken steps to ensure that EU citizens can continue to come and work in the NHS once we have left the EU. In March 2019, we put in place legislation that ensures the continued recognition of qualifications from EU countries by all professional regulators covering the health and social care sectors. This means that EU citizens will continue to be able to come and practice in the UK once we have left the EU, even if we leave without a deal.</p>
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property question first answered
less than 2019-05-22T14:54:38.56Zmore like thismore than 2019-05-22T14:54:38.56Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
1796
unstar this property label Biography information for Lord Taylor of Warwick more like this
1125835
star this property registered interest false more like this
star this property date less than 2019-05-09more like thismore than 2019-05-09
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Dental Health: Antibiotics more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government, further to the Written Answer by Lord O'Shaughnessy on 4 December 2018 (HL11750), how many antibiotic prescriptions were issued by general dental practitioners in England in 2018. more like this
star this property tabling member printed
Lord Colwyn more like this
star this property uin HL15625 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2019-05-22more like thismore than 2019-05-22
star this property answer text <p>The Dental Prescribing Dashboard developed by the NHS Business Services Authority and Public Health England, includes data for National Health Service local area teams. Latest available data show general dental practitioners issued 2,912,579 prescriptions for all antimicrobials including antibiotics during April 2017 to March 2018. There were 715,545 prescriptions between January and March 2018. The Dental Prescribing Dashboard will be refreshed in summer 2019.</p><p>Analysis is based on items prescribed by NHS dentists, but some patients may attend a general medical practice with a dental infection and receive a prescription from their general practitioner (GP). These prescriptions are not included, as we cannot determine the reason why a GP prescribed antibiotics.</p><p>The <em>English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) Report 2018</em> provides information on NHS dental prescribing in dental practices and consultations. The ESPAUR report for 2019 scheduled for publication later this year will publish data for the 2018 calendar year. The ESPAUR 2018 report is attached.</p>
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property question first answered
less than 2019-05-22T14:52:22.64Zmore like thismore than 2019-05-22T14:52:22.64Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property attachment
1
star this property file name ESPAUR_2018_report.pdf more like this
star this property title ESPAUR_2018_report more like this
star this property tabling member
3394
unstar this property label Biography information for Lord Colwyn more like this
1126002
star this property registered interest false more like this
star this property date less than 2019-05-13more like thismore than 2019-05-13
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cancer more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effect of medical nutrition on clinical outcomes for cancer patients. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon more like this
star this property uin 253575 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2019-05-21more like thisremove minimum value filter
star this property answer text <p>The National Institute for Health and Care Excellence (NICE) guidance on ‘Oesophago-gastric cancer: assessment and management in adults’ (2018) cautions that while nutrition support can improve surgical outcomes, practice in this field varies nationally so its effectiveness has not been determined.</p> more like this
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-05-21T10:53:13.567Zmore like thismore than 2019-05-21T10:53:13.567Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this